GB1841 is an orally active and selective galectin inhibitor with human galectin-1 K d of 0.027 μM, human galectin-3 K d of 0.14 μM, mouse galectin-1 K d of 0.034 μM and mouse galectin-3 K d of 1.170 μM. GB1841 can be used for the research of lung cancer .
Products | Products > Disease Areas > Cancer | Products > Disease Areas > Lung Cancer | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Signaling Pathways > Galectin
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.